ExpediteBio and AVS Bio Partner to Enable Fully Integrated Developability Driven Antibody Development and Manufacturing

NIZO food research and Winclove Probiotics join forces in strategic partnership built on interdependency and microbial innovation

Genmab Announces Positive Phase 3 Results for Epcoritamab Plus Lenalidomide in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma, Demonstrating Statistically Significant Improvement in Progression-Free Survival

After the Bench: What the BioBusiness Summer School 2026 Taught Me

MindCapture and Strand join forces to shape the future of life sciences in Belgium

TargED Raises €40.4M Series A2 to Advance First-in-Class Targeted Thrombolytic TGD001

Agomab Announces Design of NOV-ERA Phase 2b Study with Ontunisertib in Fibrostenosing Crohn’s Disease

Alturos Therapeutics advancement of lead candidate

Product naar patiënt. Het kan sneller. Het kan beter.

Zo pakt Noord-Nederland het groeiende tekort aan mensen en kennis in Life Sciences & Health aan

What will women do when AI takes over our jobs?

Confo Therapeutics Announces Encouraging Preclinical Data for Post-bariatric Hypoglycemia Candidate CFTX-2034 at ENDO 2026

Matisse Pharmaceuticals receives FDA Fast Track Designation for isupartob sodium in sepsis

Leading Without Limits: A Woman’s Journey in Biotech Leadership

New investment from UHSF & Graduate Ventures in Visualise.bio

Werken bij het CBG

KWF and Oncode Institute join forces for breakthroughs in cancer research

Can type 2 diabetes be reversed through personalized nutrition?

Ona Therapeutics Raises $86.6 Million Series B to Advance First-in-Class ADCs into Clinical Development

Beyond Antibodies: Clear2Cure Develops Therapeutics That Eliminate Disease-Causing Proteins

MRM Health rewarded a €2.6M VLAIO Research Grant to accelerate the development of novel therapeutics that redefine the treatment of immunemediated inflammatory diseases